Management Strategies in Antithrombotic Therapy

Author: Arman Askari  

Publisher: John Wiley & Sons Inc‎

Publication year: 2008

E-ISBN: 9780470518144

P-ISBN(Hardback):  9780470319383

Subject: R973 blood and hemopoietic system drugs

Language: ENG

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Description

Intravascular thrombus formation remains one of the most significant problems in cardiovascular medicine. It underlies the clinical presentation of acute coronary syndromes, including unstable angina and non-ST-segment elevation myocardial infarction (NSTEMI) and ST-segment elevation myocardial infarction.

More and more individuals are stricken with an acute MI and undergo a percutaneous coronary intervention (PCI). Several reasons apply, including an increasingly aged population, the growing burden of chronic risk factors such as diabetes, obesity, sedentary behaviour, and improvements in early recognition and intervention. Thrombus formation also results in substantial morbidity and mortality. Despite significant advances in prevention and treatment of venous thromboembolism, pulmonary embolism remains a common preventable cause of hospital deaths. Implementing the most appropriate, and safe, anticoagulation therapy across the spectrum of cardiovascular disease in the presence of a wide range of other risk factors remains a challenge.

Written by leading authorities in the field, Management Strategies in Antithrombotic Therapy offers a comprehensive review of antithrombotic therapy, including the latest therapies, risk factors and evidence-based strategy. The book acquaints readers with the data behind the commonly used antithrombotic agents and assists them in formulating a sound, evidence-based therapeutic strategy appropriate for each patient.

This book is an invaluable resource for all postgraduate students and specialist physicians in cardiovascular medicine, cardiac and vascular surgery, and critical care.

Chapter

Contents

pp.:  1 – 9

Abbreviations and Acronyms

pp.:  9 – 13

Preface

pp.:  13 – 17

Chapter 2 Aspirin

pp.:  19 – 31

Chapter 3 Thienopyridines – Ticlopidine and Clopidogrel

pp.:  31 – 55

Chapter 4 Platelet Glycoprotein IIb/IIIa Inhibitors

pp.:  55 – 95

Chapter 5 Unfractionated Heparin

pp.:  95 – 121

Chapter 6 Low-Molecular-Weight Heparins

pp.:  121 – 147

Chapter 7 Direct Thrombin Inhibitors

pp.:  147 – 179

Chapter 8 Fibrinolytic agents

pp.:  179 – 199

Chapter 9 Acute ST-Segment-Elevation Myocardial Infarction

pp.:  199 – 223

Chapter 10 Acute Coronary Syndromes: Unstable Angina / Non-ST-Segment-Elevation Myocardial Infarction (NSTE ACS)

pp.:  223 – 251

Chapter 11 Anticoagulation Strategies for Patients Undergoing Percutaneous Coronary Intervention

pp.:  251 – 277

Chapter 12 Venous Thromboembolic Disease

pp.:  277 – 301

Chapter 13 Heparin-Induced Thrombocytopenia

pp.:  301 – 335

Index

pp.:  335 – 361

Plates

pp.:  361 – 369

LastPages

pp.:  369 – 372

The users who browse this book also browse


No browse record.